Table I.
Number of primary melanomas in MPM patients according to CDKN2A status
| CDKN2A + | CDKN2A WT | ||||
|---|---|---|---|---|---|
| Group of analysis | No. | % | No. | % | p-value |
| All MPM patients | |||||
| 2 | 34 | 12.6 | 236 | 87.4 | |
| 3 | 11 | 21.2 | 41 | 78.8 | <0.001 |
| ≥4 | 12 | 48.0 | 13 | 52.0 | |
| SMP | |||||
| 2 | 12 | 6.3 | 179 | 93.7 | |
| 3 | 5 | 15.6 | 27 | 84.4 | 0.015 |
| ≥4 | 3 | 27.3 | 8 | 72.7 | |
| FMP | |||||
| 2 | 22 | 27.8 | 57 | 72.2 | |
| 3 | 6 | 30.0 | 14 | 70.0 | 0.033 |
| ≥4 | 9 | 64.3 | 5 | 35.7 | |
CDKN2A +: patients with mutation; WT: wild-type patients; MPM: Multiple Primary Melanoma; SMP: Sporadic multiple primary melanoma patient; FMP: Familial multiple primary melanoma patient